Relay Therapeutics (RLAY) Change in Account Payables (2020 - 2024)
Historic Change in Account Payables for Relay Therapeutics (RLAY) over the last 5 years, with Q3 2024 value amounting to -$4.3 million.
- Relay Therapeutics' Change in Account Payables fell 25188.22% to -$4.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$6.4 million, marking a year-over-year decrease of 22870.43%. This contributed to the annual value of -$2.4 million for FY2023, which is 22036.2% down from last year.
- According to the latest figures from Q3 2024, Relay Therapeutics' Change in Account Payables is -$4.3 million, which was down 25188.22% from $3.2 million recorded in Q2 2024.
- In the past 5 years, Relay Therapeutics' Change in Account Payables registered a high of $4.6 million during Q3 2022, and its lowest value of -$5.4 million during Q4 2023.
- In the last 5 years, Relay Therapeutics' Change in Account Payables had a median value of -$56000.0 in 2021 and averaged -$46210.5.
- Within the past 5 years, the most significant YoY rise in Relay Therapeutics' Change in Account Payables was 82845.91% (2022), while the steepest drop was 595000.0% (2022).
- Over the past 5 years, Relay Therapeutics' Change in Account Payables (Quarter) stood at $1.3 million in 2020, then soared by 89.63% to $2.4 million in 2021, then decreased by 19.15% to $2.0 million in 2022, then tumbled by 373.21% to -$5.4 million in 2023, then grew by 19.99% to -$4.3 million in 2024.
- Its Change in Account Payables stands at -$4.3 million for Q3 2024, versus $3.2 million for Q2 2024 and $102000.0 for Q1 2024.